Scarica l'app Stockscreener
0.0942
3.88%
-0.0038
Dopo l'orario di chiusura:
.09
-0.0042
-4.46%
Precedente Chiudi:
$0.098
Aprire:
$0.1
Volume 24 ore:
6.33M
Relative Volume:
0.27
Capitalizzazione di mercato:
$8.14M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.80%
1M Prestazione:
-48.97%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.0904
$0.1033
Intervallo di 1 settimana:
$0.0805
$0.1094
Portata 52W:
$0.0651
$2.22
Profusa Inc Stock (PFSA) Company Profile
Nome
Profusa Inc
Settore
Industria
Telefono
212-494-9022
Indirizzo
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Confronta PFSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.0942 | 8.47M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Profusa Inc Borsa (PFSA) Ultime notizie
Renowned Greek surgeon adopts new tech to track tissue oxygen at home - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Profusa (NASDAQ: PFSA) outlines reverse split plan to address Nasdaq listing rules - Stock Titan
Profusa, Inc.Common Stock (NQ: PFSA - FinancialContent
Profusa restructures senior secured convertible notes - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Profusa expands European footprint with French distributor partnership By Investing.com - Investing.com Nigeria
Profusa expands European footprint with French distributor partnership - Investing.com India
Profusa Bolsters European Commercial Network with New French Distributor, MedSell - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring - ts2.tech
Manufacturing Stocks To Add to Your Watchlist – December 30th - Defense World
New French deal brings oxygen monitoring tech to critical limb patients - Stock Titan
Nio, Profusa, Nike, FTAI Aviation And Under Armour: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Profusa (PFSA) Stock Analysis Report | Financials & Insights - Benzinga
Profusa Stock Soars—To 12 Cents—On Debt Restructuring - Sahm
Profusa (PFSA) Stock: Announces Key Changes to Senior Secured Convertible Notes for Stronger Financial Health - parameter.io
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nasdaq Trading Activity: Profusa Leads High-Volume Movers on December 30, 2025News and Statistics - IndexBox
Profusa amends securities purchase agreement to allow for $5 million note sale - Investing.com Nigeria
Here’s Why Profusa Stock (PFSA) Rocketed Today - TipRanks
US Stocks Lower; Home Price Growth Eases in October - Sahm
Profusa Restructures Senior Secured Convertible Notes; Shares Jump Pre-Bell - MarketScreener
Profusa restructures convertible note to reduce dilution, increase flexibility - Investing.com
Profusa amends securities purchase agreement to allow for $5 million note sale By Investing.com - Investing.com South Africa
Profusa restructures convertible note to reduce dilution, increase flexibility By Investing.com - Investing.com South Africa
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 - The Manila Times
Profusa Signs Amendment No. 3 to Securities Purchase Agreement With Ascent Partners Fund - TradingView — Track All Markets
[8-K] Profusa, Inc. Reports Material Event | PFSA SEC FilingForm 8-K - Stock Titan
Digital health firm revamps debt terms to reduce share dilution - Stock Titan
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Profusa amends equity deal and convertible note terms - MSN
[424B3] Profusa, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Profusa amends securities agreements with Ascent Partners Fund - Investing.com India
Profusa Amends Equity Deal and Convertible Note Terms - TipRanks
Profusa amends securities agreements with Ascent Partners Fund By Investing.com - Investing.com UK
Profusa Updates Multiple Financing Agreements With Ascent Partners Fund - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa (NASDAQ:PFSA) versus ReShape Lifesciences (OTCMKTS:RSLSD) Financial Contrast - Defense World
Profusa’s Lumee oxygen monitoring meets key endpoints in PAD study By Investing.com - Investing.com Nigeria
Profusa’s Lumee oxygen monitoring meets key endpoints in PAD study - Investing.com
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 - The Manila Times
Profusa U.S. study met primary end points as presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 - marketscreener.com
Profusa U.S. Study Met Primary End Points As Presented At Late Breaking Clinical Trials At Paris Vascular Insights 2025 - TradingView — Track All Markets
Profusa (Nasdaq: PFSA) U.S. Lumee PAD study hits endpoints, backs potential FDA filing - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 - The Manila Times
Profusa (Nasdaq: PFSA) to share US pilot PAD Lumee data at LINC 2026 in Leipzig - Stock Titan
The growth track for Profusa Inc (PFSA) has changed recently - setenews.com
Profusa, Inc. Common Stock (PFSA) -5.4% in Intraday Trading: Decline Despite Positive Clinical Update - Stocks Telegraph
Profusa Inc Azioni (PFSA) Dati Finanziari
Non sono disponibili dati finanziari per Profusa Inc (PFSA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.31%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):